VAV3 Recombinant Antibody

$Blocking buffer: 5% NFDM\/TBST Primary Ab dilution: 1:2000 Primary Ab incubation condition: 2 hours at room temperature Secondary Ab: Goat Anti-Rabbit IgG H&L\r\n(HRP) Lysate: 1: Human placenta, 2: Mouse placenta, 3: Rat kidney Protein loading quantity: 20 \u03bcg Exposure time: 60 s Predicted MW: 98 kDa Observed MW: 98 kDa$

Blocking buffer: 5% NFDM\/TBST Primary Ab dilution: 1:2000 Primary Ab incubation condition: 2 hours at room temperature Secondary Ab: Goat Anti-Rabbit IgG H&L\r\n(HRP) Lysate: 1: Human placenta, 2: Mouse placenta, 3: Rat kidney Protein loading quantity: 20 \u03bcg Exposure time: 60 s Predicted MW: 98 kDa Observed MW: 98 kDa

Applications

Reactivity

Human

Predicted Reactivity

Mouse
Rat

Overview
Catalog #	bsm-60661r
Product Name	VAV3 Recombinant Antibody
Applications	WB
Reactivity	Human
Predicted Reactivity	Mouse, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human VAV3
Modification Site	Ser39
Clonality	Recombinant
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	10451
Swiss Prot	Q9UKW4
Subcellular location	Cytoplasm, Extracellular matrix
Synonyms	Guanine nucleotide exchange factor VAV3; Protein vav 3; Protein vav3; VAV 3; VVAV-3; av 3 guanine nucleotide exchange factor; VAV 3 oncogene; VAV 3 protein; VAV-3; VAV3 oncogene; VAV3 protein; VAV3_HUMAN.
Application Dilution
WB	1:300-5000